[Adverse effects of drugs acting on the upper digestive system: anti-ulcer agents and modifiers of motoricity].
D000535:Aluminum / Q000009:adverse effects; D000818:Animals; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D001570:Benzodiazepinones / Q000009:adverse effects; D001729:Bismuth / Q000009:adverse effects; D002229:Carbenoxolone / Q000009:adverse effects; D004294:Domperidone / Q000009:adverse effects; D006801:Humans; D008787:Metoclopramide / Q000009:adverse effects*; D009942:Organometallic Compounds; D010276:Parasympatholytics / Q000009:adverse effects; D010890:Pirenzepine; D013392:Sucralfate; D014299:Trimipramine / Q000009:adverse effects
D000897:Anti-Ulcer Agents; D001570:Benzodiazepinones; D009942:Organometallic Compounds; D010276:Parasympatholytics; D010890:Pirenzepine; D013392:Sucralfate; D004294:Domperidone; D014299:Trimipramine; D000535:Aluminum; C002791:bismuth tripotassium dicitrate; D008787:Metoclopramide; D002229:Carbenoxolone; D001729:Bismuth
Effets secondaires d'autres médicaments à visée digestive supérieure: anti-ulcéreux, modificateurs de la motricité.